RWA Wealth Partners LLC Buys 565 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

RWA Wealth Partners LLC raised its position in UnitedHealth Group Incorporated (NYSE:UNH) by 1.0% in the fourth quarter, HoldingsChannel.com reports. The fund owned 60,031 shares of the healthcare conglomerate’s stock after purchasing an additional 565 shares during the quarter. RWA Wealth Partners LLC’s holdings in UnitedHealth Group were worth $30,368,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently modified their holdings of the company. Norges Bank acquired a new position in shares of UnitedHealth Group in the fourth quarter valued at $6,375,744,000. Raymond James Financial Inc. bought a new position in UnitedHealth Group in the 4th quarter valued at about $1,914,740,000. Amundi boosted its holdings in shares of UnitedHealth Group by 97.2% during the fourth quarter. Amundi now owns 6,069,100 shares of the healthcare conglomerate’s stock worth $3,183,132,000 after acquiring an additional 2,991,470 shares during the period. Proficio Capital Partners LLC lifted its holdings in UnitedHealth Group by 76,830.4% during the 4th quarter. Proficio Capital Partners LLC now owns 1,888,641 shares of the healthcare conglomerate’s stock worth $955,388,000 after purchasing an additional 1,886,186 shares during the last quarter. Finally, Caisse DE Depot ET Placement DU Quebec increased its position in UnitedHealth Group by 129.7% during the 3rd quarter. Caisse DE Depot ET Placement DU Quebec now owns 1,029,540 shares of the healthcare conglomerate’s stock worth $601,951,000 after buying an additional 581,324 shares during the period. 87.86% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

UNH has been the topic of a number of recent research reports. Hsbc Global Res raised shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. Oppenheimer boosted their price target on UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. Barclays dropped their price objective on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a report on Friday, January 17th. Wells Fargo & Company dropped their price target on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. Finally, Truist Financial decreased their target price on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Twenty equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Buy” and a consensus price target of $629.32.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of the firm’s stock in a transaction that occurred on Friday, January 17th. The stock was acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the purchase, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this link. 0.33% of the stock is currently owned by corporate insiders.

UnitedHealth Group Stock Performance

UnitedHealth Group stock opened at $515.47 on Friday. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The company has a market capitalization of $471.51 billion, a P/E ratio of 33.26, a P/E/G ratio of 1.37 and a beta of 0.62. The business has a 50 day moving average of $508.81 and a 200-day moving average of $544.24.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. UnitedHealth Group’s revenue for the quarter was up 6.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted $5.83 earnings per share. On average, equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were issued a dividend of $2.10 per share. The ex-dividend date was Monday, March 10th. This represents a $8.40 annualized dividend and a yield of 1.63%. UnitedHealth Group’s payout ratio is 54.19%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.